Malaria Parasitaemia among Different Haemoglobin Genotypes in Federal Capital Territory, Abuja

Download Article

DOI: 10.21522/TIJPH.2013.07.01.Art018

Authors : Udo Stella Ngozi


Malaria is a common and life-threatening disease in many tropical and subtropical areas and transmitted by the female Anopheles mosquitoes with major impact on global public health. It is endemic in Nigeria with up to 97% of the population at risk. Malaria results to 60% outpatient visits to healthcare facilities,25% childhood death, and11% maternal death. Haemoglobin genotype variants have been implicated in reducing malaria parasite replication within the red blood cells and enhance splenic clearance in malaria parasitized erythrocytes. The study of the Malaria parasitaemia among different haemoglobin genotypes in Federal Capital Territory, Abuja, is aimed at determining the effect of haemoglobin genotypes on malaria parasitaemia among residents in FCT. (2mls) of venous blood was collected from 384 randomly selected residents. Determination of malaria parasitaemia was by Microscopy and the cellulose acetate membrane electrophoresis was used for heamoglobin genotype. A structured questionnaire created with Epi-Info version 7 for data collection and analysis. Results of 187 volunteers with malaria parasitaemia indicated that: malaria parasitaemia was more in female (58.8%) and male (41.4%); age groups of 0-10 (42.0%), 11-20 (35.2%) and 21-30(14.5%) and 91.7% within age range of 0-30 years of the studied group; in Gwagwalada (24.6%), followed by Bwari (21.4%), Kuje (18.7%), Kwali (17.7%), Abaji (15.5%) and was least in AMAC (2.1%) and severe ((+++) (> 10,000/ µL)) in blood genotype AA(47.4%) than in AS(0.0%), AC(0.0%) and least in SS(0.0%). It was concluded that malaria and the haemoglobin S gene were endemic in FCT and variant Haemoglobin C and S could confer protection to malaria parasitaemia.

Keywords: Malaria, Parasitaemia, Haemoglobin Genotypes.


[1].     Aidoo, M., Terlouw, D.J., Kolezak M.S., McElroy P. D and TerKuile, F.O., (2002). Protective Effects of the Sickle Cell Gene against Malaria Morbidity and Mortality.Lancet.359,1311-1312.

[2].     Allison, A.C (2002). The discovery of Resistance to Malaria by Sickle Cell Heterozygotes. Biochemistry and Molicular Biology Education,30, 279-287.

[3].     Alouch AI. Sickle cell disease and Malaria parasitaemia in a tropical setting. Journal

[4].     Biological Chemistry. 1997.12, 23-30. 

[5].Awah, F M; Nwanedo, G.; Olalekan, S I; Augusta EhijieAzeke, A E; and Mbaik, N (June, 2012): A possible protective role of glucose-6-phosphate dehydrogenase deficiency and sickle haemoglobin genes against severe malaria in Madonna University, Elele Community. Journal Medicinal and Medical Sciences3(6), 375-381.

[6].     Awah F.M. and Uzoegwu, P.N (2006). Influence of sickle heterozygous status and glucose-6-phosphate dehydrogenase deficiency on the clinicohaematolgoical profile of Plasmodium falciparum-infected children. Biokemistri.18(2), 89-97.

[7].     Bell DR, Jorgensen P, Christophel EM, Palmer KL (2005). Malaria risk: estimation of the malaria burden. Nature 437: E3-E4.

[8].     Bhandari PL, Raghuveer CV, Rajeev A, Bhandari PD (2008). Comparative study of peripheral blood smear, quantitative buffy coat and modified centrifuged blood smear in malaria diagnosis. Indian Journal of Pathology. 51: 108-112.

[9].     Burn GW (1976). The Science of Genetics. 3rd Edition, Collier Macmillan Publications, London.

[10]. CDC (2008). Malaria Facts. [Accessed September 10, 2018]. Available at:

[11]. CDC. (2003) Local Transmission of Plasmodium vivax Malaria --- Palm Beach County, Florida, 2003. MMWR 52:908-911.

[12]. Cheesbrough M (2000). District laboratory Practice in Tropical Countries Part 2. University Press, Cambridge: 271-340.

[13]. Clark, I. A; Alleva, L. M.; Mills, A. C. and Cowden, W. B. (July, 2004): Pathogenesis of Malaria and Clinically Similar Conditions. Clinical Microbiology Reviews, 509–539.

[14]. Diana Garza and Kathleen Becan-McBride (1993): Phlebotomy Handbook., 3rd edition. 103-148. Appleton & Lange, Norwalk, Connecticut.

[15]. Endeshaw T, Gebre T, Ngondi J, Graves PM, Shargie EB, Ejigsemahu Y, Ayele B, Yohannes G, Teferi T, Messele A, Zerihun M, Genet A, Mosher AW, Emerson PM, Richards FO (2008). Evaluation of light microscopy and rapid diagnostic test for the detection of malaria under operational field conditions: a household survey in Ethiopia. Malaria Journal. 7: 118.

[16]. Evans D.I.K (1971). Haemoglobin Electrophoresis on Cellulose Acetate Using Whole Blood Samples.Journal Clinical Pathology 2,: 877–878.

[17]. Harvey SA, Jennings L, Chinyama M, Masaninga F, Mulholland K, Bell DR (2008). Improving community health worker use of malaria rapid diagnostic tests in Zambia: package instructions, job aid and job aid-plus-training. Malaria Journal. 7: 160.

[18]. Holland CA and Kiechle FL (2005). Point-of-care molecular diagnostic systems-past, present and future. Current Opinion in Microbiology. 8: 504509.

[19]. Lee SW, Jeon K, Jeon BR, Park I (2008). Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present. Journal of Clinical Microbiology. 46: 939-942.

[20]. Looareesuwan S (1999). Malaria. In: Looareesuwan S, Wilairatana P eds, Clinical Tropical Medicine. 1st ed. Bangkok, Thailand Medical Media. p 5-10.

[21]. Ilozumba PC, Uzozie CR. Prevalence of malaria parasitaemia and its association with ABO Blood Group in Odoakpu Area of Onitsha South Local Government Area, Anambra State Nigeria. Nigerian Annals of Natural Sciences. 2009.8(2),1-8.

[22]. John VD, Lewis M (1986). Practical Haematology 6th edition. Longman Singapore Publishers Pte Ltd., Churchill Livingstone.179-200.

[23]. Koch AA, Olney RS, Yang Q (2000). Sickle Hemoglobin Allele and Sickle Cell Disease. American Journal of Epidemiology 9: 839-845.

[24]. McMorrow ML, Masanja MI, Abdulla SM, Kahigwa E, Kachur SP. Challenges in routine implementation and quality control of rapid diagnostic tests for malaria-Rufiji District, Tanzania. American Journal of Tropical Medicine and Hygiene 2008; 79: 385-390.

[25]. Modiano D, Luoni G, Sirima BS, Langrancotti A, Petrarca V, Cruciani F, Simpore J, Ciminelli BM, Foglietta E, Grisanti P, Bianco I, Modiano G, Coluzzi M (2001). The Lower Susceptibility of Plasmodium falciparum Malaria to Fulani of Burkina Faso (West Africa) is Associated with Low Frequencies of Classic Malaria-Resistance Genes. Transactions of the Royal Society of Tropical Medicine and Hygiene. 95,149–152.

[26]. Mwangi TW, Mohammed M, Dayo H, Snow RW, Marsh K. Clinical algorithms for malaria diagnosis lack utility among people of different age groups. Tropical Medicine of Internal Health 2005; 10: 530-536.

[27]. Ngasala B, Mubi M, Warsame M, Petzold MG, Massele AY, Gustafsson LL, Tomson G, Premji Z, Bjorkman A(2008). Impact of training in clinical and microscopy diagnosis of childhood malaria on antimalarial drug prescription and health outcome at primary health care level in Tanzania: a randomized controlled trial. Malaria Journal 7: 199.

[28]. NPC, (2006). The Nigerian Population Census Data, National Population Commission.

[29]. Okoduwa, S. I. R. (Nov. 2013). Blood Group and Genotype Compartibility. Infohealth Awareness Article. 1 (2), 84-87.

[30]. Ogbu G.I. ; Aimakhu, CO; Anzaku, SA; Ngwan, S and Ogbu, DA(2015). Prevalence of malaria parasitaemia among asymptomatic women at booking visit in a tertiary hospital, North Central Nigeria. Journal of Reproductive Biology and Health Vol 3

[31]. Otajevwo, F D. (June, 2012): An Investigation Into Heterozygous Haemoglobin Genotype Association With Malaria Parasitaemia In A Community School Based In Benin City, Nigeria. Global Research Journal of Medical Sciences.2 (2).023 – 03.

[32]. Ratsimbasoa A, Fanazava L, Radrianjafy R, Ramilijaona J, Rafanomezantsoa H, Mecnard D (2008). Evaluation of two new immunochromatographic assays for diagnosis of malaria. American Journal of Tropical Medicine and Hygiene. 79: 670-672.

[33]. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, Whitty CJ (2007). Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. British Medical Journal. 334: 403.

[34]. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, Saganda K, Shao J, Kitua A, Olomi R, Greenwood BM, Whitty CJ. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ 2004; 329: 1212.

[35]. Tangpukdee, N.; Duangdee,C.; Wilairatana, P. and Krudsood, S.(June, 2009). Malaria Diagnosis: An Overview. Korean Journal of Parasitology. Vol. 47, No. 2: 93-102.

[36]. Tagbor H, Bruce J, Browne E, Greenwood B, Chandramohan D (2008). Performance of the OptiMAL dipstick in the diagnosis of malaria infection in pregnancy. Therapy in Clinical Risk Management. 4: 631-636.

[37]. Tidi S.K, Amos J.T, Firyanda E (2013). Association between Plasmodium infection, Haemoglobin genotypes and Blood groups among Under-five nomadic Fulani of Northea eastern Nigeria.International Journal of Malaria Research and Reviews.1(2): 7-11.

[38]. UNICEF (2000). Promoting Rational Use of Drugs and Correct Case Management in Basic Health Services, UNICEF’s Programme Division in cooperation with the World Health Organization.

[39]. World Health Organization (2013). World Malaria Report 2013. World Health Organization, Geneva.

[40]. WHO (2012). Management of severe malaria: a practical handbook, third edition. Geneva.

[41]. WHO (2010). Guidelines for the treatment of malaria, second edition. Geneva.

[42]. WHO (2006). Malaria vector control and personal protection: report of a WHO Study Group. Geneva, World Health Organization, 2006 (WHO Technical Report Series, No. 936).

[43]. WHO (2000). WHO expert committee on MALARIA 20th REPORT. Who Technical Report Series 892. Geneva.

[44]. Zerpa N, Pabon R, Wide A, Gavidia M, Medina M, Caceres JL, CapaldoJ, Baker M, Noya O (2008). Evaluation of the OptiMAL test for diagnosisof malaria in Venezuela. Investigations in Clinical Chemistry. 49: 93-101.